Olanzapine pamoate
双羟萘酸奥氮平
Report date: 2024/08/12 20:00:30
Base Information
Drug NameOlanzapine pamoate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2008/11/19
Country/Territory +[14]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesCheplapharm Arzneimittel GmbhEli Lilly And Company
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A